Reddy

Dr Reddy’s Laboratories to challenge patents on drug

Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day marketing exclusivity to its generic Omeprazole 40 mg capsules by the US Food and Drug Administration. Omeprazole is indicated for the treatment of duodenal and gastric ulcers. The FDA granted the marketing exclusivity to Andrx group of the US....

Dr Reddy’s Laboratories launches Hyalosy

The Hyderabad-based Dr Reddy’s Laboratories has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that provides relief from knee-joint stiffness and immobility among patients suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent disease. More than 90 per cent of people above the age of 45 are estimated to show signs of this disease, and it is the leading ca...

AAI Pharma Files Lawsuit Against Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRL) has been slapped with a lawsuit for patent infringement by the US based AAI Pharma Inc for the generic version of the anti-depressant drug Prozac. DRL has a 180 days exclusivity to sell the drug's 40 mg dosage form along with Barr Laboratories that holds the exclusivity for the 10 and 20 mg dosage forms. DRL expects this to be a routine move as the para IV filing af...

Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru

Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience A/S for the joint development of a drug to treat diabetes. // Under the pact, Rheoscience will fund all costs associated with the Phase-III clinical trials of balaglitazone (DRF 2593), a partial PPAR-gamma agonist, for the treatment of type 2 diabe...

Dr Reddy's Launches Generic Version Of Mercks Proscar Tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched the authorized generic version of Merck's Proscar tablets 5 mg (Finasteride) on June 19. // The company has also launched the authorized generic version of Merck's Zocor tablets (Simvastatin) 5 mg, 10 mg, 20 mg, 40 mg and 80 mg yesterday, a company release said. In January this year, the company ente...

Dr Reddys Launches New Drug In Its Urology Segment

Consolidating its position in the urology segment, pharma major Dr Reddys Laboratories Ltd has introduced a drug Alfuzosin Hydrochloride available// in extended release tablets of 10 mg dosage. Alfuzosin Hydrochloride, introduced under the brand name 'Alfoo' is indicated for treatment of enlargement of prostate gland in ageing men known as Benign Prostatic Hyperplasia (BPH), a compan...

Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease

Indian pharma major Dr. Reddy's Laboratories will launch a first-of-its-kind pill to tackle heart diseases in the second half of 2007, it was announced Thursday. // The company has teamed up with researchers at University of Auckland, New Zealand, for trials of the groundbreaking 'polypill' that combines four medicines including aspirin and statin, commonly used to treat heart ailment...

Dr. Reddy's To Invest $100 Mn In Andhra

Indian pharma major Dr. Reddy's Laboratories (DRL) is all set to invest nearly Rs. 4.5 billion ($100 million) as part of their expansion drive in Andhra Pradesh, the company's home state. // 'As part of our plan, $100 million will be invested within the next 18 months for increasing our capacity in the field of formulations, Active Pharmaceuticals Ingredients (API) and Custom Pharmaceu...

A Combined Heart Pill-developed by Dr. Reddy’

Dr. Reddy’s, the Indian pharma giant has decided to join hands with the University of Auckland, //New Zealand to begin Global trials of a new fixed dose combination or “polypills” to prevent strokes and heart attacks. The polypill will combine four drugs- aspirin, statin(to reduce cholesterol) and two drugs to prevent hypertension. The trial will check the reliability of the pill when...

Dr Reddy's Eyeing for Generics Arm of Merck

Dr Reddy's Laboratories, one of India's largest manufacturers of generic medicines,// is the latest Indian company working on putting in a bid for a major European company - the generics arm of German pharmaceuticals giant Merck. "We will take a look at it and then decide," G.V. Prasad, Dr Reddy's vice-chairman and chief executive officer, told The Times here. He added that any bid fr...

Reddy Asks Stanford University to Open Hyderabad Campus

Andhra Pradesh Chief Minister Y.S. Rajasekhara Reddy, who is on a visit to the US, has asked Stanford University to set up an offshore campus in Hyderabad, promising to provide all necessary infrastructure. The chief minister made the request after the signing of an MoU between Stanford University, the Andhra government and Satyam Computers' EMRI (Emergency Management and Research...